Business · 19/05/2004
FDA Releases Guidance for Industry on HIV Treatment Combination Products
The Food and Drug Administration (FDA) has released a guidance for industry on developing fixed dose combination and co-packaged drug products for treating HIV, aiming to boost patient adherence and simplify treatment distribution.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →